| Ident. | Authors (with country if any) | Title |
|---|
| 000132 |
M. Jourdain [France] | Syndrome de Wolff-Parkinson-White |
| 000155 |
Etienne C. Hirsch [France] | Futures pistes thérapeutiques médicamenteuses pour la maladie de Parkinson |
| 000161 |
V. Chhor [France] ; A.-L. Schang [France] ; G. Favrais [France] ; B. Fleiss [France, Royaume-Uni] ; P. Gressensa [France, Royaume-Uni] | Conséquences cérébrales à long terme de l'inflammation périnatale |
| 000203 |
Henrik Hagberg [Suède, Royaume-Uni] ; Pierre Gressens [Royaume-Uni, France] ; Carina Mallard [Suède] | Inflammation during Fetal and Neonatal Life: Implications for Neurologic and Neuropsychiatric Disease in Children and Adults |
| 000232 |
Sophie Schumm [France] ; Claude Sebban [France] ; Charles Cohen-Salmon [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Jean-Louis Golmard [France] ; Lydie Boussicault [France] ; Isabelle Petropoulos [France] ; Audrey Hild [France] ; Estelle Rousselet [France] ; Annick Prigent [France] ; Bertrand Friguet [France] ; Jean Mariani [France] ; Etienne C. Hirsch [France] | Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine |
| 000275 |
J.-C. Stoclet [France] ; V. Schini-Kerth [France] | Flavonïdes alimentaires et santé humaine |
| 000586 |
Frédéric Dolle [France] ; Christopher Luus [Australie] ; Aaron Reynolds [Australie] ; Michael Kassiou [Australie] | Radiolabelled Molecules for Imaging the Translocator Protein (18 kDa) Using Positron Emission Tomography |
| 000696 |
P. Ravanan [France] ; C. Rouch [France] ; C. Lefebvre D'Hellencourt [France] | Influence de l'obésité sur les phénomènes neurodégénératifs |
| 000942 |
R. Bordet [France] ; T. Ouk [France] ; S. Gautier [France] ; M. Laprais [France] ; D. Deplanque [France] ; P. Gele [France] ; M. Bastide [France] | Les récepteurs nucléaires PPAR : une nouvelle cible en neuropharmacologie ? |
| 000A06 |
Valentina Vasina [Italie] ; Giovanni Barbara [Italie] ; Luigia Talamonti [Italie] ; Vincenzo Stanghellini [Italie] ; Roberto Corinaldesi [Italie] ; Marcello Tonini [Italie] ; Fabrizio De Ponti [Italie] ; Roberto De Giorgio [Italie] | Enteric neuroplasticity evoked by inflammation |
| 000C46 |
Carlos Barcia [Espagne] ; Angel Sanchez Bahillo [Espagne] ; Emiliano Fernandez-Villalba [Espagne] ; Victor Bautista [Espagne] ; Maximo Poza Y. Poza [Espagne] ; Andrés Fernandez-Barreiro [Espagne] ; Etienne C. Hirsch [France] ; Maria-Trinidad Herrero [Espagne] | Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure |
| 000C92 |
A. Destee [France] | Neuroprotection et syndromes parkinsoniens neurodégénératifs |
| 000D35 |
Guillaume Hebert [France] ; Josette Arsaut [France] ; Robert Dantzer [France] ; Jacques Demotes-Mainard [France] | Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin |
| 000D59 |
Stephane Hunot [France] ; E. C. Hirsch [France] | Neuroinflammatory processes in Parkinson's disease. Discussion |
| 000E45 |
P.-P. Michel [France] ; E.-C. Hirsch [France] ; Yves Agid [France] | Maladie de Parkinson : mécanismes de la mort cellulaire |
| 001051 |
Carine Fillebeen [France] ; Marie-Magdeleine Ruchoux [France] ; Valérie Mitchell [France] ; Sylvie Vincent [France] ; Monique Benaïssa [France] ; Annick Pierce [France] | Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor a or 1-methyl-4-phenylpyridinium treatment |
| 001257 |
| La lactoferrine cérébrale : Origines et mécanismes d'accumulation au cours des maladies neurodégénératives |
| 001374 |
| Réaction gliale et processus inflammatoires dans la maladie de Parkinson |
| 001447 |
E. C. Hirsch [France] ; S. Hunot [France] ; P. Damier [France] ; B. Faucheux [France] | Glial cells and inflammation in Parkinson's disease : A role in neurodegeneration? |
| 001660 |
M. Spedding [France] ; M. Williams [États-Unis] | Developments in purine and pyridimidine receptor-based therapeutics |
